Authors:
BEEMSTERBOER PMM
WARMERDAM PG
BOER R
BORRAS JM
MORENO V
VILADIU P
DEKONING HJ
Citation: Pmm. Beemsterboer et al., SCREENING FOR BREAST-CANCER IN CATALONIA - WHICH POLICY IS TO BE PREFERRED, European journal of public health, 8(3), 1998, pp. 241-246
Authors:
BEEMSTERBOER PMM
WARMERDAM PG
BOER R
DEKONING HJ
Citation: Pmm. Beemsterboer et al., RADIATION RISK OF MAMMOGRAPHY RELATED TO BENEFIT IN SCREENING PROGRAMS - A FAVORABLE BALANCE, Journal of medical screening, 5(2), 1998, pp. 81-87
Authors:
BOER R
DEKONING H
THRELFALL A
WARMERDAM P
STREET A
FRIEDMAN E
WOODMAN C
Citation: R. Boer et al., COST-EFFECTIVENESS OF SHORTENING SCREENING INTERVAL OR EXTENDING AGE RANGE OF NHS BREAST SCREENING-PROGRAM - COMPUTER-SIMULATION STUDY, BMJ. British medical journal, 317(7155), 1998, pp. 376-379
Authors:
BECK JF
BUCHHOLZ F
ULRICH WR
BOER R
SANDERS KH
NIETHAMMER D
GEKELER V
Citation: Jf. Beck et al., RHODAMINE-123 EFFLUX MODULATION IN THE PRESENCE OF LOW OR HIGH SERUM FROM CD56(-CELLS OR CD34(+) LEUKEMIC BLASTS BY B9309-068, A NEWLY DESIGNED PYRIDINE DERIVATIVE() HEMATOPOIETIC), Cancer letters, 129(2), 1998, pp. 157-163
Authors:
ELTZE M
KLEIN T
GREBE T
HAAS S
MIRAU B
BOER R
Citation: M. Eltze et al., POTENCY AND SELECTIVITY OF INHIBITORS OF INDUCIBLE AND ENDOTHELIAL NITRIC-OXIDE SYNTHASE IN RAT AORTA CORRELATE WITH HUMAN ISOZYMES, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 182-182
Citation: J. Fracheboud et al., NATIONWIDE BREAST-CANCER SCREENING IN THE NETHERLANDS - RESULTS OF INITIAL AND SUBSEQUENT SCREENING 1990-1995, International journal of cancer, 75(5), 1998, pp. 694-698
Authors:
VANBALLEGOOIJEN M
BECK S
BOON ME
BOER R
HABBEMA JDF
Citation: M. Vanballegooijen et al., RESCREEN EFFECT IN CONVENTIONAL AND PAPNET SCREENING - OBSERVED IN A STUDY USING MATERIAL ENRICHED WITH POSITIVE SMEARS, Acta cytologica, 42(5), 1998, pp. 1133-1138
Citation: G. Stevens et al., METAMORPHISM, FLUID-FLOW, AND GOLD MOBILIZATION IN THE WITWATERSRAND BASIN - TOWARDS A UNIFYING MODEL, South African journal of geology, 100(4), 1997, pp. 363-375
Authors:
WARMERDAM PG
DEKONING HJ
BOER R
BEEMSTERBOER PMM
DIERKS ML
SWART E
ROBRA BP
Citation: Pg. Warmerdam et al., QUANTITATIVE ESTIMATES OF THE IMPACT OF SENSITIVITY AND SPECIFICITY IN MAMMOGRAPHIC SCREENING IN GERMANY, Journal of epidemiology and community health, 51(2), 1997, pp. 180-186
Authors:
SNOEIJER AB
BOER R
HARTWIG M
MOSTERT R
BOHMER TJM
Citation: Ab. Snoeijer et al., TEMPERATURE CONTROL FROM CONVERTER TO TUNDISH AT BOS NO-2 OF HOOGOVENS, Revue de métallurgie, 94(10), 1997, pp. 1195-1201
Citation: R. Boer et al., A COMPARISON OF DISEASE-SPECIFIC SURVIVAL OF PATIENTS WHO DIED OF ANDWHO HAD NEWLY-DIAGNOSED PROSTATE-CANCER, The Journal of urology, 157(5), 1997, pp. 1768-1771
Authors:
VANDENAKKERVANMARLE ME
REEPVANDENBERGH CMM
BOER R
DELMORAL A
ASCUNCE N
DEKONING HJ
Citation: Me. Vandenakkervanmarle et al., BREAST-CANCER SCREENING IN NAVARRA - INTERPRETATION OF A HIGH DETECTION RATE AT THE FIRST SCREENING ROUND AND A LOW-RATE AT THE 2ND-ROUND, International journal of cancer, 73(4), 1997, pp. 464-469
Citation: Hj. Dekoning et al., RE - QUANTITATIVE INTERPRETATION OF AGE-SPECIFIC MORTALITY REDUCTIONSFROM THE SWEDISH BREAST CANCER-SCREENING TRIALS - RESPONSES, Journal of the National Cancer Institute, 88(1), 1996, pp. 54-54
Authors:
BOER R
GEKELER V
ULRICH WR
ZIMMERMANN P
ISE W
SCHODL A
HAAS S
Citation: R. Boer et al., MODULATION OF P-GLYCOPROTEIN MEDIATED DRUG ACCUMULATION IN MULTIDRUG-RESISTANT CCRF VCR-1000 CELLS BY CHEMOSENSITIZERS, European journal of cancer, 32A(5), 1996, pp. 857-861
Citation: R. Boer et al., COST-EFFECTIVENESS OF MAMMOGRAPHY SCREENING, JAMA, the journal of the American Medical Association, 275(2), 1996, pp. 111-112
Authors:
ELTZE M
BOER R
SANDERS KH
PRUSSE W
ULRICH WR
Citation: M. Eltze et al., B8805-033 - AN EXTREMELY ALPHA(1A)-ADRENOCEPTOR-SELECTIVE ANTAGONIST, Naunyn-Schmiedeberg's archives of pharmacology, 354(4), 1996, pp. 35-35
Authors:
BOER R
ULRICH WR
HAAS S
BORCHERS C
GEKELER V
BOSS H
PRZYBYLSKI M
SCHODL A
Citation: R. Boer et al., INTERACTION OF CYTOSTATICS AND CHEMOSENSITIZERS WITH THE DEXNIGULDIPINE BINDING-SITE ON P-GLYCOPROTEIN, European journal of pharmacology, 295(2-3), 1996, pp. 253-260
Authors:
GEKELER V
BOER R
UBERALL F
ISE W
SCHUBERT C
UTZ I
HOFMANN J
SANDERS KH
SCHACHTELE C
KLEMM K
GRUNICKE H
Citation: V. Gekeler et al., EFFECTS OF THE SELECTIVE BISINDOLYLMALEIMIDE PROTEIN-KINASE-C INHIBITOR GF 109203X ON P-GLYCOPROTEIN-MEDIATED MULTIDRUG-RESISTANCE, British Journal of Cancer, 74(6), 1996, pp. 897-905
Authors:
BOER R
DICHTL M
BORCHERS C
ULRICH WR
MARECEK JF
PRESTWICH GD
GLOSSMANN H
STRIESSNIG J
Citation: R. Boer et al., REVERSIBLE LABELING OF A CHEMOSENSITIZER BINDING DOMAIN OF P-GLYCOPROTEIN WITH A NOVEL 1,4-DIHYDROPYRIDINE DRUG TRANSPORT INHIBITOR, Biochemistry, 35(5), 1996, pp. 1387-1396
Citation: Hj. Dekoning et al., QUANTITATIVE INTERPRETATION OF AGE-SPECIFIC MORTALITY REDUCTIONS FROMTHE SWEDISH BREAST CANCER-SCREENING TRIALS, Journal of the National Cancer Institute, 87(16), 1995, pp. 1217-1223
Authors:
BOER R
DEKONING HJ
VANOORTMARSSEN GJ
VANDERMAAS PJ
Citation: R. Boer et al., INCIDENCE OF INTERVAL CANCER AND DETECTION RATE OF FIRST SCREENINGS ARE INCONSISTENT, BMJ. British medical journal, 310(6985), 1995, pp. 1002-1002
Authors:
PACI E
BOER R
ZAPPA M
DEKONING HJ
VANOORTMARSSEN GJ
CROCETTI E
GIORGI D
DELTURCO MR
HABBEMA JDF
Citation: E. Paci et al., A MODEL-BASED PREDICTION OF THE IMPACT ON REDUCTION IN MORTALITY BY ABREAST-CANCER SCREENING-PROGRAM IN THE CITY OF FLORENCE, ITALY, European journal of cancer, 31A(3), 1995, pp. 348-353
Citation: R. Boer, CHRISTOLOGICAL SLIPPAGE AND IDEOLOGICAL STRUCTURES IN SCHWARZENEGGER 'TERMINATOR' + EXPLORING THE INTERTEXTUAL INTERFACE BETWEEN THE BIBLE AND THE ORTHODOX CHRISTOLOGY IN CAMERON,JAMES FILMS, Semeia, (69-70), 1995, pp. 165-193